PRESS RELEASE published on 12/04/2024 at 07:30, 1 year 5 months ago Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream Nicox announces first commercial sale of ZERVIATE in China by partner Ocumension, creating new revenue stream. ZERVIATE, cetirizine ophthalmic solution, treats allergic conjunctivitis in China market China Ophthalmology Nicox ZERVIATE Ocumension
PRESS RELEASE published on 12/04/2024 at 07:30, 1 year 5 months ago Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, créant ainsi une nouvelle source de revenus récurrents. Lancement du collyre approuvé en septembre 2024 Chine Ophtalmologie Nicox ZERVIATE Ocumension
BRIEF published on 11/19/2024 at 07:35, 1 year 6 months ago Nicox Publishes Adaptive Design Results for NCX 470 Phase 3 Trial Phase 3 Trial Nicox Glaucoma Treatment Clinical Results NCX 470
BRIEF published on 11/19/2024 at 07:35, 1 year 6 months ago Nicox publie les résultats de la conception adaptative de l'essai de phase 3 du NCX 470 Essai De Phase 3 Nicox Traitement Du Glaucome Résultats Cliniques NCX 470
PRESS RELEASE published on 11/19/2024 at 07:30, 1 year 6 months ago Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Nicox announces the publication of the adaptive design period of the NCX 470 Mont Blanc Phase 3 trial, selecting 0.1% concentration due to better intraocular pressure reduction and safety profile Phase 3 Trial Ophthalmology Nicox NCX 470 Adaptive Design
PRESS RELEASE published on 11/19/2024 at 07:30, 1 year 6 months ago Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470, dévoilant une réduction significative de la pression intraoculaire avec une concentration de 0,1 %, confirmant son choix pour les études en cours Étude Clinique Ophtalmologie Nicox NCX 470 Glaucome
BRIEF published on 10/14/2024 at 07:35, 1 year 7 months ago Nicox et Soleus signent un accord de financement de 16,5 millions de dollars Financement Nicox NCX 470 Soleus Capital VYZULTA
BRIEF published on 10/14/2024 at 07:35, 1 year 7 months ago Nicox and Soleus sign $16.5 million financing agreement Funding Nicox NCX 470 Soleus Capital VYZULTA
PRESS RELEASE published on 10/14/2024 at 07:30, 1 year 7 months ago Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Nicox et Soleus concluent un accord de financement de 16,5 millions de dollars, combinaison de vente de redevances et fonds propres, visant à soutenir le développement du NCX 470 en ophtalmologie Accord De Financement Ophtalmologie Nicox NCX 470 Soleus
PRESS RELEASE published on 10/14/2024 at 07:30, 1 year 7 months ago Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Nicox and Soleus sign $16.5 million royalty and equity financing agreement, reducing debt burden and financing into Q3 2025. Topline results expected in Q3 2025 for NCX 470 Denali Phase 3 trial Equity Financing Nicox NCX 470 Soleus Royalty
Published on 05/22/2026 at 08:00, 2 hours 33 minutes ago Caledonia Mining Corporation Plc: Refiling of Bilboes Gold Project Feasibility Study National Instrument 43-101 Technical Report
Published on 05/21/2026 at 23:00, 11 hours 33 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 11 hours 33 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 11 hours 33 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/22/2026 at 10:00, 33 minutes ago Shanghai Electric Marks International Day for Biological Diversity with Localized Green Practices
Published on 05/22/2026 at 10:00, 33 minutes ago 2026 Annual General Meeting: Fresenius delivers strong performance in 2025 and proposes 5% increase in dividends
Published on 05/22/2026 at 10:00, 33 minutes ago Nabaltec AG once again honored with the Best Managed Companies Award
Published on 05/22/2026 at 09:12, 1 hour 21 minutes ago Aroundtown SA announces publication of convening notice for the 2026 Annual General Meeting
Published on 05/22/2026 at 09:11, 1 hour 22 minutes ago Grand City Properties S.A. announces publication of convening notice for the 2026 Annual General Meeting
Published on 05/22/2026 at 08:30, 2 hours 3 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 2 hours 3 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
Published on 05/21/2026 at 17:45, 16 hours 48 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 16 hours 48 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE